accountELADUR�� (TRANSDUR��-Bupivacaine), DURECT's proprietary investigational transdermal bupivacaine pain patch. This study was conducted by DURECT's collaborator, King Pharmaceuticals, which is now owned by Pfizer (NYSE: PFE). In this study of 263 patients...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to DURECT Announces ELADUR�� (TRANSDUR��-Bupivacaine) Phase II Study Results In Chronic Low Back Pain
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account